{"id":"W3021606747","doi":"10.14740/jocmr4162","title":"Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Hazard ratio; Internal medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Confidence interval; Oncology; Gastroenterology; Urothelial carcinoma; Cancer; Bladder cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006982526,0.0001452243,0.0003736471,0.0002920328,0.0004207023,0.0005015054,0.0001821605,0.000279159,0.0005974509],"category_scores_gemma":[0.001549319,0.0001082494,0.0003069654,0.0004614783,0.0002381745,0.0003508391,0.0003282849,0.0002484141,0.0001289085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003249993,"about_ca_system_score_gemma":0.000589372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001386796,"about_ca_topic_score_gemma":0.003582797,"domain_scores_codex":[0.9996815,0.0001203573,0.00005049189,0.00004814892,0.00005065766,0.00004889685],"domain_scores_gemma":[0.9992452,0.00006773918,0.0004413017,0.00003092126,0.00008580906,0.0001291353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007384853,0.000259348,0.921307,0.000510333,0.0002809172,0.002098102,0.0009895271,0.0002572392,0.004289425,0.00009728601,0.001429218,0.06774305],"study_design_scores_gemma":[0.0002135226,0.001640406,0.9711689,0.0002444584,0.0006371689,0.0101909,0.001992035,0.001189447,0.0009747104,0.0002192916,0.01150268,0.00002658628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891176,0.009131846,0.0003028827,0.0004675556,0.00002279489,0.00003778655,0.00004764212,0.000006468291,0.0008654722],"genre_scores_gemma":[0.9941096,0.004657851,0.0005709831,0.0003158565,0.00005496207,0.00002942629,0.0001051116,0.000002322902,0.0001538216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001386796,"threshold_uncertainty_score":0.003692746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2112767851094266,"score_gpt":0.5336645998358557,"score_spread":0.3223878147264291,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}